Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Connect Biopharma Holdings Ltd

Current price
1.71 USD +0.02 USD (+1.18%)
Last closed 1.76 USD
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 96 981 280 USD
Yield for 12 month +54.07 %
21.11.2021 - 28.11.2021

Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, engages in the development of therapies for the treatment of T cell-driven inflammatory diseases. The company is building a pipeline of small molecules and antibodies using functional T cell assays to screen and discover potent product candidates against validated immune targets. Its lead product candidate is rademikibart (formerly CBP-201), an antibody designed to target interleukin-4 receptor alpha, which is a validated target for the treatment of inflammatory diseases such as atopic dermatitis and asthma, currently under Phase 3 studies; and icanbelimod (formerly CBP-307), an oral small molecule Sphingosine 1-Phosphate Receptor 1 modulator, currently under Phase 2 clinical for the treatment of ulcerative colitis and Crohn's disease. The company was founded in 2012 and is based in San Diego, California. Address: 12265 El Camino Real, San Diego, CA, United States, 92130

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
MSFT MSFT Microsoft


WallStreet Target Price

7.12 USD

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

Last Year

Current Quarter

Last Quarter

Key Figures CNTB

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -64 233 000 USD
Operating Margin TTM
PE Ratio
Return On Assets TTM -27.07 %
PEG Ratio
Return On Equity TTM -46.03 %
Wall Street Target Price 7.12 USD
Revenue TTM
Book Value 1.83 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings per share -1.08 USD
Diluted Eps TTM -1.08 USD
Most Recent Quarter I 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics CNTB

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History CNTB

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation CNTB

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 1.8695
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA 0.0603
Price Book MRQ 0.737

Financials CNTB

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators CNTB

For 52 weeks

0.53 USD 2.84 USD
50 Day MA 1.6 USD
Shares Short Prior Month 31 231
200 Day MA 1.22 USD
Short Ratio 0.69
Shares Short 54 141
Short Percent 0.17 %

Dynamics of changes in the value of assets




430.32 USD Microsoft Corporation +0.69 (+0.16%)
Detailed analytics

ETF funds



14.75 EUR iShares EURO STOXX Banks 30-15 UCITS ETF (DE) 0 (0%)
Detailed analytics



2357.98 USD Gold +6.23 (+0.27%)
Detailed analytics